Destination

2025-01-14

Maker of weight-loss drugs to ask Trump to pause price negotiations: Report

The next 15 drugs up for negotiation will be released soon and may include a GLP-1. [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination

2025-01-03

The best smart scales for 2025

The New Year is here and there’s no better time to kickstart those health and fitness goals. Whether you’re looking to shed a few holiday pounds, track your muscle gains or simply stay on top of a [...]

Match Score: 115.63

thenextweb

2025-01-10

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 98.79

Destination

2025-06-06

Trump reportedly plans to extend the pause on the TikTok ban yet again

President Donald Trump plans to extend the pause on enforcing the TikTok ban once again, The Wall Street Journal reports. Trump previously extended the pause on April 4 to give TikTok, its potential U [...]

Match Score: 74.98

Destination

2025-04-23

Eli Lilly is stepping up its fight against copycat weight-loss drugs

In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss dr [...]

Match Score: 73.27

Destination

2025-05-13

Weight loss drugs are squeezing the food industry

The revolutionary GLP-1 class of weight loss drugs are racking up blockbuster sales at a pace rarely seen in the pharmaceutical industry. But the pharma industry’s gain is the food industry’s loss [...]

Match Score: 70.54

Destination

2025-02-01

What will happen to TikTok? A look at the potential buyers.

TikTok may be back online, but the app’s future in the United States is still far from certain. President Donald Trump’s executive order delaying enforcement of the ban was only a temporary reprie [...]

Match Score: 68.64

Destination

2025-05-30

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 64.84

Destination

2025-04-10

Nintendo may sell the Switch 2 at a loss in the US due to tariffs

The Nintendo Switch 2 is functionally similar to its predecessor. Sure, the detachable controllers can now each be used as a mouse (on your pants, no less), the screen is bigger, the hardware is more [...]

Match Score: 62.88

Destination

2025-05-20

Noom is offering microdoses of compounded Wegovy for weight loss

Noom will start offering microdoses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health company continues to adapt to the growing demand for affordable weight-loss solu [...]

Match Score: 60.10